Accès à distance ? S'identifier sur le proxy UCLouvain
A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès restreint |
Publication date | 2009 |
Language | Anglais |
Journal information | "Journal of Cerebral Blood Flow and Metabolism" - Vol. 29, no. 10, p. 1665-1672 (2009) |
Peer reviewed | yes |
Publisher | Nature Publishing Group ((United States) New York) |
issn | 0271-678X |
e-issn | 1559-7016 |
Publication status | Publié |
Affiliations |
UCL
- (SLuc) Service de néphrologie UCL - MD/MINT - Département de médecine interne |
Keywords | Angiotensin receptor ; Blood pressure ; Cerebral infarction ; Neuroprotection ; Oxidative stress |
Links |
- Bederson J. B., Pitts L. H., Tsuji M., Nishimura M. C., Davis R. L., Bartkowski H., Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination, 10.1161/01.str.17.3.472
- Brdon Jan, Kaiser Sabine, Hagemann Friederike, Zhao Yi, Culman Juraj, Gohlke Peter, Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke : , 10.1097/01.hjh.0000254376.80864.d3
- Castillo J., Blood Pressure Decrease During the Acute Phase of Ischemic Stroke Is Associated With Brain Injury and Poor Stroke Outcome, 10.1161/01.str.0000109769.22917.b0
- Chen Shan, Ge Yan, Si Jin, Rifai Abdalla, Dworkin Lance D., Gong Rujun, Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade, 10.1038/ki.2008.380
- Dai Q, Xu M, Yao M, Sun B, Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats : AT1A inhibits vessel wall inflammation, 10.1038/sj.bjp.0707454
- Engelhorn Tobias, Goerike Sophia, Doerfler Arnd, Okorn Christine, Forsting Michael, Heusch Gerd, Schulz Rainer, The Angiotensin II Type 1—Receptor Blocker Candesartan Increases Cerebral Blood Flow, Reduces Infarct Size, and Improves Neurologic Outcome after Transient Cerebral Ischemia in Rats, 10.1097/00004647-200404000-00012
- Faure S, J Physiol Pharmacol, 57, 329 (2006)
- Fischberg Glenn M., Lozano Edward, Rajamani Kumar, Ameriso Sebastian, Fisher Mark J., Stroke precipitated by moderate blood pressure reduction, 10.1016/s0736-4679(00)00267-5
- Forder J. P., Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat, 10.1152/ajpheart.00839.2004
- Groth Wolf, Blume Annegret, Gohlke Peter, Unger Thomas, Culman Juraj, Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats : , 10.1097/00004872-200311000-00028
- Ito T., Yamakawa H., Bregonzio C., Terron J. A., Falcon-Neri A., Saavedra J. M., Protection Against Ischemia and Improvement of Cerebral Blood Flow in Genetically Hypertensive Rats by Chronic Pretreatment With an Angiotensin II AT1 Antagonist, 10.1161/01.str.0000027274.03779.f3
- Iwai M., Possible Inhibition of Focal Cerebral Ischemia by Angiotensin II Type 2 Receptor Stimulation, 10.1161/01.cir.0000138848.58269.80
- Izuhara Y., Renoprotective Properties of Angiotensin Receptor Blockers beyond Blood Pressure Lowering, 10.1681/asn.2005050522
- Izuhara Y., Nangaku M., Takizawa S., Takahashi S., Shao J., Oishi H., Kobayashi H., van Ypersele de Strihou C., Miyata T., A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models, 10.1093/ndt/gfm601
- Izuhara Y., Sada T., Yanagisawa H., Koike H., Ohtomo S., Dan T., Ito S., Nangaku M., van Ypersele de Strihou C., Miyata T., A Novel Sartan Derivative With Very Low Angiotensin II Type 1 Receptor Affinity Protects the Kidney in Type 2 Diabetic Rats, 10.1161/atvbaha.108.172841
- Lander Harry M., Tauras James M., Ogiste Jason S., Hori Osamu, Moss Rebecca A., Schmidt Ann Marie, Activation of the Receptor for Advanced Glycation End Products Triggers a p21ras-dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress, 10.1074/jbc.272.28.17810
- Longa E. Z., Weinstein P. R., Carlson S., Cummins R., Reversible middle cerebral artery occlusion without craniectomy in rats, 10.1161/01.str.20.1.84
- Lou Min, Blume Annegret, Zhao Yi, Gohlke Peter, Deuschl Günther, Herdegen Thomas, Culman Juraj, Sustained Blockade of Brain AT1 Receptors before and after Focal Cerebral Ischemia Alleviates Neurologic Deficits and Reduces Neuronal Injury, Apoptosis, and Inflammatory Responses in the Rat, 10.1097/00004647-200405000-00008
- Miyata T., Angiotensin II Receptor Antagonists and Angiotensin-Converting Enzyme Inhibitors Lower In Vitro the Formation of Advanced Glycation End Products: Biochemical Mechanisms, 10.1097/01.asn.0000032418.67267.f2
- Nangaku M., Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model, 10.1097/01.asn.0000062961.76776.c1
- Nishimura Y., Ito T., Saavedra J. M., Sandberg K., Angiotensin II AT1 Blockade Normalizes Cerebrovascular Autoregulation and Reduces Cerebral Ischemia in Spontaneously Hypertensive Rats Editorial Comment, 10.1161/01.str.31.10.2478
- Savitz Sean I., Fisher Marc, Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials, 10.1002/ana.21127
- Schroeter M., Jander S., Huitinga I., Witte O. W., Stoll G., Dietrich W. D., Phagocytic Response in Photochemically Induced Infarction of Rat Cerebral Cortex: The Role of Resident Microglia, 10.1161/01.str.28.2.382
- Semplicini Andrea, Benetton Valentina, Mascagna Vania, Macchini Luisa, Realdi Anna, Sartori Michelangelo, Calò Lorenzo, Problems Related to Short-Term Antihypertensive Therapy in Acute Ischemic Stroke, 10.1080/10641960600549421
- Takizawa Shunya, Izuhara Yuko, Kitao Yasuko, Hori Osamu, Ogawa Satoshi, Morita Yuko, Takagi Shigeharu, van Ypersele de Strihou Charles, Miyata Toshio, A novel inhibitor of advanced glycation and endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia, 10.1016/j.brainres.2007.07.006
- Umemura K., Wada K., Uematsu T., Nakashima M., Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model, 10.1161/01.str.24.7.1077
- Wackenfors Angelica, Vikman Petter, Nilsson Elisabeth, Edvinsson Lars, Malmsjö Malin, Angiotensin II-induced vasodilatation in cerebral arteries is mediated by endothelium-derived hyperpolarising factor, 10.1016/j.ejphar.2005.11.064
- Wityk Robert J, Lewin John J, Blood pressure management during acute ischaemic stroke, 10.1517/14656566.7.3.247
- Yan SD, J Biol Chem, 269, 9889 (1994)
- Yatsu Frank M., Hypertension in Acute Ischemic Strokes : Not to Treat, 10.1001/archneur.1985.04060090081018
- Zhou Jin, Ando Hiromichi, Macova Miroslava, Dou Jingtao, Saavedra Juan M, Angiotensin II AT1 Receptor Blockade Abolishes Brain Microvascular Inflammation and Heat Shock Protein Responses in Hypertensive Rats, 10.1038/sj.jcbfm.9600082
Bibliographic reference | Takizawa, Shunya ; Dan, Takashi ; Uesugi, Tsuyoshi ; Nagata, Eiichiro ; Takagi, Shigeharu ; et. al. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage. In: Journal of Cerebral Blood Flow and Metabolism, Vol. 29, no. 10, p. 1665-1672 (2009) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/35271 |